# Lymphangioleiomyomatosis, a Study on Cathepsin K

> **NCT05323370** · — · COMPLETED · sponsor: **University Hospital, Tours** · enrollment: 19 (actual)

## Conditions studied

- Lymphangioleiomyomatosis
- Tuberous Sclerosis Complex

## Interventions

- **OTHER:** 24h urine
- **OTHER:** urine sample

## Key facts

- **NCT ID:** NCT05323370
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-31
- **Primary completion:** 2022-10-30
- **Final completion:** 2022-10-30
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2023-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05323370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05323370, "Lymphangioleiomyomatosis, a Study on Cathepsin K". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05323370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*